The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation

Leuk Res. 2013 Sep;37(9):1052-6. doi: 10.1016/j.leukres.2013.06.013. Epub 2013 Jul 3.

Abstract

Hematopoietic-cell-transplantation-specific-comorbidity-index (HCT-CI) has been reported as a predictor of survival in allogeneic-transplant recipients; however its validity has recently been challenged. We evaluated the association of HCT-CI with survival of transplant recipients who underwent reduced-intensity-conditioning (RIC) with photopheresis, pentostatin, and total-body-irradiation. Median age of 103 patients selected was 55 years. Most patients (58.3%) had high (≥ 3) HCT-CI. Median OS was 298 days. Age, disease-type, disease-status, HCT-CI correlated with survival on bivariate analysis. On multivariate analysis, only HCT-CI was significantly associated with OS (low HCT-CI HR=0.29, CI 0.091-0.886; intermediate HCT-CI HR=0.41, CI 0.226-0.752). Our findings suggest HCT-CI as an independent predictor of survival in the setting of RIC transplants.

Keywords: Hematopoietic cell transplantation specific comorbidity index; Non-relapse mortality; Overall survival; Reduced intensity conditioning.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Comorbidity
  • Female
  • Follow-Up Studies
  • Hematologic Neoplasms / mortality*
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Middle Aged
  • Pentostatin / therapeutic use*
  • Photopheresis*
  • Prognosis
  • Remission Induction
  • Retrospective Studies
  • Survival Rate
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Whole-Body Irradiation*

Substances

  • Pentostatin